| 20 | ℹ |
UBT251, a novel triple GLP-1, GIP, and glucagon receptor agonist, in adults with overweight or obesity: A multicenter, randomized phase 2 trial.
(linkinghub.elsevier.com)
|
Cell Metabolism 2026-10-07 | #clinical trial #obesity #metabolic #pharmacology #cardiovascular | |
| 4 | ℹ |
Escherichia coli-derived enterobactin is associated with delayed gut microbiome maturation in infants born to mothers with obesity.
(journals.asm.org)
|
mSystems 2026-10-07 | #microbiome #amr #metagenomics #virulence #obesity |